EquityFlow
›
Companies
› Ichrogene
Ichrogene
Biotech
· Seoul, KR
Genetic-analysis company predicting chronic disease and cancer
Funding history
Date
Round
Amount
May 2021
Funding round
Ichrogene, a Korean genetic-analysis company, raised KRW 3B to improve its genetic big-data analysis.
—
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →